D-0097-2023 Class II

Recalled by Pfizer Inc. — New York, NY

Recall Details

Product Type
Drugs
Report Date
January 11, 2023
Initiation Date
December 29, 2022
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
62,088 bags

Product Description

Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,

Reason for Recall

Lack of assurance of sterility: Bags have the potential to leak.

Distribution Pattern

Nationwide in the USA.

Code Information

Lot: 5935283, Exp. 12/01/2023